Dobutamine 51662-1337-03
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 26, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA074086
Need to source Dobutamine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dobutamine Hydrochloride | 12.5 mg/mL |
Drug Class
Adrenergic beta-Agonists [MoA]beta-Adrenergic Agonist [EPC]
Selected Package
51662-1337-03Selected10 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
20 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1)